As a visionary founder, Jeff Geschwind, MD established Cage Pharma. His research here focuses on novel cancer drugs that target tumor metabolism, seeking to disrupt the energy source of cancer cells and create powerful new treatment options for oncology patients. https://www.academia.edu/143398007/Targeting_Tumor_Glycolysis_A_Promising_Frontier_in_Cancer_Therapy